Doxylamine succinate
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313431This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H22N2O.C4H6O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V9BI9B5YI2, chemically known as succinic acid, compd. with 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine (1:1) (8ci) but more generally known as doxylamine hydrogen succinate, which bears US NIH Compound Identifier 11224. European Medicines Agency schedules Doxylamine hydrogen succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11925MIG. Most nations, for tariff and trade purposes, schedule doxylamine succinate under HS 29333999 and SITC 51574. As of Q4 2014, DOXYLAMINE SUCCINATE remains US FDA's Preferred Term for this commodity. Doxylamine succinate bears US NLM identifiers UMLS ID C0058733 and NCI Concept Code C47501. SMILES: CC(C1CCCCC1)(C2CCCCN2)OCCN(C)C.C(CC(=O)O)C(=O)O.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.